Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma.

Leukemia & lymphoma - 1 Feb 2003

Cunningham L M, Chapman C, Dunstan R, Bell M C, Joske D J L

Abstract excerpt

Interleukin-10 (IL-10) is mainly an anti-inflammatory cytokine produced by a number of cells including normal and neoplastic B cells. It has been implicated in autoimmunity, transplantation tolerance and tumourigenesis. Polymorphisms in the IL-10 gene promoter genetically determine inter-individual differences in IL-10 production. The aim of this study was to determine whether polymorphisms in the IL-10 gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Gene Frequency
Share to Haplotypes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hodgkin Disease

Share to Interleukin-10

Share to Lymphoma, Non-Hodgkin

Share to Polymerase Chain Reaction

Share to Promoter Regions, Genetic

Source

Identifiers

PMID: 12688341
DOI: 10.1080/1042819021000035590

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma.PMID 12688341Read ↗

Interleukin‐10 gene polymorphisms influence the clinical course of non‐Hodgkin’s lymphomaSemantic proximity Read ↗

Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma.Semantic proximity Read ↗

Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.Semantic proximity Read ↗

Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.Semantic proximity Read ↗

Epstein-Barr virus infection and single nucleotide polymorphisms in the promoter region of interleukin 10 gene in patients with Hodgkin lymphoma.Semantic proximity Read ↗

Interleukin-10 Polymorphisms in Association with Prognosis in Patients with B-Cell Lymphoma Treated by R-CHOPSemantic proximity Read ↗

Relationship between IL-10 gene polymorphisms and the risk of non-Hodgkin lymphoma: A meta-analysis.Semantic proximity Read ↗

Genetic association of interleukin-10 promoter polymorphisms and susceptibility to diffuse large B-cell lymphoma: a meta-analysis.Semantic proximity Read ↗

Interleukin-10 polymorphisms, cancer susceptibility and prognosis.Semantic proximity Read ↗

Cytokine gene polymorphisms, cancer susceptibility, and prognosis.Semantic proximity Read ↗

Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma.Semantic proximity Read ↗

Inflammatory breast cancer: High incidence of GCC haplotypes (-1082A/G, -819T/C, and -592A/C) in the interleukin-10 gene promoter correlates with over-expression of interleukin-10 in patients' carcinoma tissues.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.